# Chimerix Inc. (CMRX)

Source: https://www.quantisnow.com/company/CMRX
Generated: 2026-11-16T22:56:54.555Z

- Ticker: CMRX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2013
- Website: chimerix.com

## About

Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox; dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy; and ONC201 a program for potentially treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

## Latest CMRX news and filings

- 2025-07-28 12:00 UTC [Leadership Update] [Lantern Pharma Announces Appointment of Dr. Lee Schalop to Board of Directors](https://www.quantisnow.com/insight/lantern-pharma-announces-appointment-of-dr-lee-schalop-to-board-6133734)
- 2025-05-01 12:51 UTC [SEC Form 15-12G filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-chimerix-inc-6012456)
- 2025-04-23 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-chimerix-inc-5997087)
- 2025-04-21 20:54 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994998)
- 2025-04-21 20:52 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994990)
- 2025-04-21 20:50 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994982)
- 2025-04-21 20:49 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994968)
- 2025-04-21 20:47 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994959)
- 2025-04-21 20:46 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994953)
- 2025-04-21 20:44 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994938)
- 2025-04-21 20:43 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994930)
- 2025-04-21 20:41 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994921)
- 2025-04-21 20:40 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994912)
- 2025-04-21 20:37 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994894)
- 2025-04-21 20:36 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994888)
- 2025-04-21 20:34 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chimerix-inc-5994879)
- 2025-04-21 20:32 UTC [SEC Form POS AM filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-chimerix-inc-5994871)
- 2025-04-21 20:17 UTC [SEC Form 4] [SEC Form 4 filed by Director Vakiener Victoria](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-vakiener-victoria-5994777)
- 2025-04-21 20:16 UTC [SEC Form 4] [Chief Executive Officer Sherman Michael A. returned $3,620,138 worth of shares to the company (423,408 units at $8.55), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-sherman-michael-a-returned-3620138-worth-of-5994774)
- 2025-04-21 20:16 UTC [SEC Form 8-K] [Chimerix Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Control of Registrant](https://www.quantisnow.com/insight/chimerix-inc-filed-sec-form-8-k-termination-of-a-material-5994773)
- 2025-04-21 20:15 UTC [SEC Form 4] [COO and CCO Riga Thomas J returned $520,079 worth of shares to the company (60,828 units at $8.55), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/coo-and-cco-riga-thomas-j-returned-520079-worth-of-5994765)
- 2025-04-21 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Director Multani Pratik S](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-multani-pratik-s-5994750)
- 2025-04-21 20:14 UTC [SEC Form 4] [Director Middleton Fred A returned $30,912,328 worth of shares to the company (3,615,477 units at $8.55), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-middleton-fred-a-returned-30912328-worth-of-shares-to-5994718)
- 2025-04-21 20:13 UTC [SEC Form 4] [Director Meyer Robert J. returned $300,532 worth of shares to the company (35,150 units at $8.55), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-meyer-robert-j-returned-300532-worth-of-shares-to-5994712)
- 2025-04-21 20:12 UTC [SEC Form 4] [CHIEF MEDICAL OFFICER Melemed Allen S. returned $1,486,435 worth of shares to the company (173,852 units at $8.55), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-melemed-allen-s-returned-1486435-worth-of-5994707)
- 2025-04-21 20:11 UTC [SEC Form 4] [CHIEF FINANCIAL OFFICER Laspaluto Michelle returned $1,552,176 worth of shares to the company (181,541 units at $8.55), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-laspaluto-michelle-returned-1552176-worth-of-shares-5994700)
- 2025-04-21 20:11 UTC [SEC Form 4] [SEC Form 4 filed by Director Kozin Marc D](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-kozin-marc-d-5994690)
- 2025-04-21 20:10 UTC [SEC Form 4] [VP OF FINANCE AND ACCOUNTING Jakeman David returned $1,335,587 worth of shares to the company (156,209 units at $8.55), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/vp-of-finance-and-accounting-jakeman-david-returned-1335587-worth-5994686)
- 2025-04-21 20:09 UTC [SEC Form 4] [Director Demski Martha J returned $616,070 worth of shares to the company (72,055 units at $8.55) (SEC Form 4)](https://www.quantisnow.com/insight/director-demski-martha-j-returned-616070-worth-of-shares-to-5994664)
- 2025-04-21 20:08 UTC [SEC Form 4] [SEC Form 4 filed by Director Decker Lisa Lynn](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-decker-lisa-lynn-5994658)
- 2025-04-21 20:07 UTC [SEC Form 4] [PRESIDENT AND CEO Andriole Michael T. returned $5,393,579 worth of shares to the company (630,828 units at $8.55), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-andriole-michael-t-returned-5393579-worth-of-5994650)
- 2025-04-21 20:06 UTC [SEC Form 4] [SVP AND GENERAL COUNSEL Alrutz Michael Albert returned $1,852,691 worth of shares to the company (216,689 units at $8.55), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/svp-and-general-counsel-alrutz-michael-albert-returned-1852691-worth-5994643)
- 2025-04-18 12:29 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Chimerix Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-chimerix-inc-5993297)
- 2025-04-17 21:12 UTC [SEC Form SCHEDULE 13G filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-chimerix-inc-5992848)
- 2025-04-16 20:10 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by Chimerix Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-chimerix-inc-5990165)
- 2025-04-07 12:01 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Chimerix Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-chimerix-inc-5978993)
- 2025-04-02 12:00 UTC [SEC Form SC14D9C filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-chimerix-inc-5971174)
- 2025-04-01 20:15 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Chimerix Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-chimerix-inc-5969765)
- 2025-03-28 12:35 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Chimerix Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-chimerix-inc-5964283)
- 2025-03-21 11:33 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Chimerix Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-chimerix-inc-5955345)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CMRX
- Earnings history: https://www.quantisnow.com/earnings/CMRX
- Dividend history: https://www.quantisnow.com/dividends/CMRX
- Insider transactions: https://www.quantisnow.com/insiders/CMRX
- Options chain: https://www.quantisnow.com/options/CMRX
- SEC 8-K filings only: https://www.quantisnow.com/company/CMRX/8-k
- RSS and alerts for CMRX: https://www.quantisnow.com/docs/rss-feeds.md
